Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer.

JAMA oncology·2026
Same author

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines.

Molecular oncology·2025
Same author

The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations.

European urology·2024
Same author

Optimizing the FDA's Project Optimus: opportunities and challenges.

Nature reviews. Clinical oncology·2023
Same author

The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.

European urology·2023
Same author

Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.

Journal of medical economics·2023
Same journal

Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.

Expert review of anticancer therapy·2026
Same journal

Barriers to the use of brachytherapy for treatment of cervical cancer and prostate cancer in low- and middle-income countries.

Expert review of anticancer therapy·2026
Same journal

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Expert review of anticancer therapy·2026
Same journal

Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies.

Expert review of anticancer therapy·2026
Same journal

RTsDEN: reverse task attention enabled deep learning model for lung cancer detection using computed tomography.

Expert review of anticancer therapy·2026
Same journal

The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinoma.

Expert review of anticancer therapy·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

19.4K

Key papers in prostate cancer.

Simon Rodney1, Taimur Tariq Shah, Hitendra R H Patel

  • 1Division of Surgery and Interventional Science, University College London, London, UK.

Expert Review of Anticancer Therapy
|October 29, 2014
PubMed
Summary
This summary is machine-generated.

Prostate cancer diagnosis and treatment evolve. Emerging evidence suggests low-grade prostate cancer can be managed with surveillance, challenging traditional radical treatments and highlighting staging dilemmas.

Keywords:
localized therapyprostate cancerradical prostatectomyscreeningwatchful waiting

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.5K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.3K

Related Experiment Videos

Last Updated: Apr 21, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

19.4K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

1.5K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.3K

Area of Science:

  • Urology
  • Oncology

Background:

  • Prostate cancer is a leading cause of death in men, with evolving diagnostic and treatment evidence.
  • Traditional approaches often involved radical surgery with significant morbidity.

Purpose of the Study:

  • To review and discuss key papers on prostate cancer diagnosis and treatment.
  • To provoke debate on current dilemmas in urological oncology.

Main Methods:

  • Review of seminal and contemporary literature on prostate cancer.
  • Discussion of screening, surgical, and non-surgical treatment strategies.

Main Results:

  • Evidence supports surveillance and localized treatment for low-grade prostate cancer.
  • Emerging data indicates not all prostate cancers require aggressive intervention.

Conclusions:

  • Accurate disease staging is crucial for selecting appropriate treatment pathways.
  • The urological community faces key dilemmas in managing prostate cancer effectively.